Annals of Indian Academy of Neurology
  Users Online: 1207 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size


 
Table of Contents
LETTER TO THE EDITOR
Year : 2017  |  Volume : 20  |  Issue : 2  |  Page : 167-169
 

Response to reader's queries


1 Department of Pharmacology, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand; Department of Pharmacology, TMMC and RC, Moradabad, Uttar Pradesh, India
2 Department of Pharmacology, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
3 Department of Psychiatry and Sleep Clinic, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
4 Department of Community Medicine, TMMC and RC, Moradabad, Uttar Pradesh, India

Date of Web Publication8-May-2017

Correspondence Address:
Ravi Gupta
Department of Psychiatry and Sleep Clinic, Himalayan Institute of Medical Sciences, Swami Ram Nagar, Jolly Grant, Dehradun - 248 016, Uttarakhand
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.AIAN_12_17

Rights and Permissions

 



How to cite this article:
Vishwakarma K, Kalra J, Gupta R, Sharma M, Sharma T. Response to reader's queries. Ann Indian Acad Neurol 2017;20:167-9

How to cite this URL:
Vishwakarma K, Kalra J, Gupta R, Sharma M, Sharma T. Response to reader's queries. Ann Indian Acad Neurol [serial online] 2017 [cited 2019 Oct 14];20:167-9. Available from: http://www.annalsofian.org/text.asp?2017/20/2/167/205761


Sir,

We are thankful to the reader for his interest in our paper and for the concerns raised. This was a noninferiority trial where we wanted to analyze whether the bupropion and iron-folate were as efficacious as ropinirole in the short-term treatment of Willis–Ekbom disease/Restless legs syndrome (WED/RLS). The consort diagram is provided with this letter [Figure 1]. As already mentioned, random allocation was done using a list of random numbers, and this has been reported to be an effective method.[1] Author who was responsible of measuring the improvement was blinded of the group allocation that removes the observer's bias. We agree with the statement mentioned that “both groups were neither superior nor equivalent to the ropinirole,” and we have already mentioned it in the paper “Pair-wise comparison depicted that ropinirole group differed from other two groups in International RLS Severity Rating (IRLS) score (F = 7.06; P= 0.001), which were comparable to each other” [Table 1].[2] As pointed out by the reader, in the absence of placebo control group, it cannot be commented whether bupropion or iron-folate combination was better than placebo. Placebo group could not be included because of restrictions from the regulatory bodies.[3] However, it must be noted that placebo is not an inert substance and this has been found effective in a number of disorders including WED/RLS.[4],[5] In this study, mixed ANOVA was used, and in this statistical method, effect size was depicted using partial eta square. In this study, partial eta square value was 0.145 with 95% power for between-subjects' effect, and thus, effect size may be considered large.[6] Intention to treat analysis, as mentioned by the reader has its own limitations. One of them is, subjects who do not receive treatment, are assumed to have taken treatment with resultant effect and this may have bearing on the results.[7] Thus, we removed five subjects who did not come for any follow up and the intention to treat analysis was done after including 8 subjects who attended at least one follow-up visit. We used last observation carry forward method of imputation. This method did not change the results as published in the initial paper.
Figure 1: Enrollment of subjects in the study

Click here to view
Table 1: Pair-wise comparison of the three groups

Click here to view


Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Kim J, Shin W. How to do random allocation (randomization). Clin Orthop Surg 2014;6:103-9.  Back to cited text no. 1
[PUBMED]    
2.
Vishwakarma K, Kalra J, Gupta R, Sharma M, Sharma T. A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis-Ekbom disease). Ann Indian Acad Neurol 2016;19:472-7.  Back to cited text no. 2
[PUBMED]  [Full text]  
3.
Ethical Guidelines for Biomedical Research on Human Participants. New Delhi: Indian Council for Medical Research; 2006.  Back to cited text no. 3
    
4.
Benedetti F. Placebo effects: From the neurobiological paradigm to translational implications. Neuron 2014;84:623-37.  Back to cited text no. 4
[PUBMED]    
5.
Fulda S, Wetter TC. Where dopamine meets opioids: A meta-analysis of the placebo effect in restless legs syndrome treatment studies. Brain 2008;131(Pt 4):902-17.  Back to cited text no. 5
    
6.
Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Front Psychol 2013;4:863.  Back to cited text no. 6
[PUBMED]    
7.
Armijo-Olivo S, Warren S, Magee D. Intention to treat analysis, compliance, drop-outs and how to deal with missing data in clinical research: A review. Physical Ther Rev 2009;14:36-49.  Back to cited text no. 7
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (298 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed1339    
    Printed19    
    Emailed0    
    PDF Downloaded32    
    Comments [Add]    

Recommend this journal